THE ROAD MAP OF HTA DEVELOPMENT: FOR WELL INFORMED HEALTH-CARE DECISIONS IN KAZAKHSTAN

Purpose: Despite significant investments during last years in clinico- and pharmacoeconomic evaluation, as part of a formulary listing or reimbursement submission, too much research is wasted and too many decisions are still not well informed. The objective was to invent the long-term strategy for the HTA development in the Republic of Kazakhstan.

Method(s): We conducted a survey of HTA terms in 6 countries (Kazakhstan, Turkey, Tajikistan, Kyrgyzstan, Uzbekistan, and Montenegro). Informal stakeholder interviews within the framework of first Eurasian Forum of HTA were used to supplement lacking information.

Result(s): Rising affordability and accessibility of the healthcare services have been considered as the most important policy issues in Kazakhstan. In light of this fact The Republican Center for Health Development is devising The Road Map of HTA Development in the Republic of Kazakhstan in 2016-2020. Healthcare professionals and managers who are responsible for seeking reliable information and learning sufficient skills to use evidence-based resources to provide optimum patient care should promote hospital based HTA on the regional level and support HTA research and CPG development in clinics. There is growing recognition of the need for local efforts that go beyond sharing the evidence. Hospital based HTA should be accountable to their patients, governments, and third party payers.

Conclusion(s): Regional HTA Agencies and National CPG developers in Kazakhstan in post carriage period would produce relevant, reliable, transparent, and up-to-date evidence synthesis and reccomendations, avoiding unnecessary duplication on regional and national levels, making thier Works accessible to decision makers, and engaging stakeholders.